Unser Educational Advisory Board, unter dem Vorsitz von Univ.-Prof. Dr. Andreas Festa, unterstützt die Strategie und die Aktivitäten der Kurse, Seminare und Kongresse der VSCR.

Augenheilkunde

Michael Amon
Michael Amon
Wien / AT

Prim. Univ. Prof. Dr. Michael Amon

Michael Amon

Wien / AT

Augenheilkunde

Geburtsdatum/-ort: 22. 12. 1961, Wien

Medizinstudium an der Universität Wien; Promotion: 9. 6. 1986

Facharztdekret für Augenheilkunde und Optometrie: 19. 10. 1992

Venia docendi: 10. 12. 1992

Ordination: Garnisongasse 18/11; 1090 Wien: 1993

Europäisches Facharztprüfungsdiplom für Augenheilkunde: 1995

Universitäts-Augenklinik Wien: 1986-2008

Vorstand der Augenabteilung der Barmherzigen Brüder Wien: 1. 7. 2008

Universitätsprofessor der MUW: 24. 8. 2009

Ordinarius der Sigmund Freud Privatuniversität Wien: seit 2016

 

Funktionen im Vorstand:

Österreichische Ophthalmologische Gesellschaft (ÖOG): 1989-1995; seit 2013

Vorsitzender der österreichischen Primarärzte: seit 2013

Präsident Wiener Ophthalmologischen Gesellschaft (WOG): 1998-1999

Vorsitz Kommission für Kataraktchirurgie und Intraokularlinsen der ÖOG: seit 2005

Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation (DGII): 2008-2012

Österreichische Augenchirurgen (ÖAC): seit 2009

Mitglied Expertengremium ÖBIG: seit 2009

Tagungspräsident der DGII: 2011

Educational Committee der European Society of Cataract and Refractive Surgery (ESCRS): seit 2012

European Society of Cataract and Refractive Surgery (ESCRS): seit 2016

 

Mitglied in Editorial Boards:

Ocular Surgery News

Cataract and Refractive Surgery Today/Europe

Spektrum der Augenheilkunde

Mitglied International Intraocular Implant Club (IIIC)

 

Chirurgie:

„Live-surgeries“ im In- und Ausland

Liste der seit 1987 durchgeführten Operationen: bis 2013

Operationskatalog: gesamt über 30.000                                         

Intraokulare Eingriffe:

Vorderabschnitt:

Hinterabschnitt:

Extraokulare Eingriffe:

Laserchirurgische Eingriffe gesamt:

  1. 600 Kataraktoperationen bei Kindern

 

Patente; Entwicklungen:

  1. Amon-Apple “enhanced square edge IOL“; Rayner Superflex, Centerflex, M-flex, T-flex, MT-flex
  1. Sulcoflex IOL; Rayner Application Number Großbritannien: 0623657.4
  1. Optirhex IOL; Zeiss Meditec Europäisches Patent; Nummer: 07018277.9-1257
  1. Phakospatel nach Amon (Firma Geuder)
  1. Kapseläquatorring (Firma Morcher; 19D)

 

Wissenschaft:

“einflussreichster Autor“: europaweit 5. Platz, weltweit 20. Platz

Citation analysis of the most influential authors and ophthalmology journals….

Clinical & Experimental Ophthalmology 36; 1; 54-61; 2008

 

über 500 wissenschaftliche Präsentationen

 

Susanne Binder
Susanne Binder
Wien / AT

Dr. Susanne Binder

Susanne Binder

Wien / AT

Augenheilkunde

Dr. med. Susanne Binder ist in Wien geboren und hat ihre medizinische Ausbildung an der Medizinischen Universität in Wien absolviert. Sie erhielt 1979/80 eine subspezialisierte Ausbildung in vitreoretinaler Chirurgie und Forschung an der Johns Hopkins Universität in Maryland und dem Duke Eye Center in Durham, beide USA.

Sie ist seit 1988 Professorin für Augenheilkunde. Im Jahr 2017 wurde sie zur Professorin für Spezielle Augenheilkunde an der Sigmund Freud Universität in Wien ernannt.

Bis 2015 war sie Vorsitzende der Abteilung für Augenheilkunde der Rudolf-Stiftung-Klinik in Wien, einem Lehrkrankenhaus der Medizinischen Universität Wien und leitete bis 2017 das Eye-Center-Projekt des Wiener Krankenanstaltenverbunds (KAV) in Wien. Darüber hinaus leitete sie den Vorsitz ein Forschungsinstitut, das Ludwig Boltzmann Institut für Retinologie und Biomikroskopische Laserchirurgie, zwischen1997 und 2015. Heute wird ihre wissenschaftliche Arbeit am Karl Landsteiner Institut für Imaging und Netzhautforschung der Rudolf Stiftung in Wien und der Sigmund Freud Universität fortgesetzt. Sie war seit 1990 stellvertretende Vorsitzende der Universitäts-Augenklinik Wien, bevor sie 1995 den Lehrstuhl (Primariat) der Rudolf-Stiftung-Klinik übernahm.

Ihre Spezialgebiete sind vitreoretinale Erkrankungen und Mikrochirurgie, Forschungen zur altersbedingten Makuladegeneration (AMD), Netzhautregenerationsbehandlungen wie Netzhautzelltransplantation und Netzhautimplantate und Bildgebung. In der Optischen Kohärenztomographie (OCT) hat sie zusammen mit Carl Zeiss Meditec / Oberkochen ein neues OCT-integriertes Mikroskop entwickelt.

Nach ihrer medizinischen Ausbildung in Wien in Augenheilkunde verbrachte sie einige Zeit an der Johns Hopkins University und der Duke University für weitere Forschung in Netzhauterkrankungen und Glaskörperchirurgie.

Dr. Binder hat mehr als 380 Original-Artikel in englischer und deutscher Sprache veröffentlicht. Sie war Chefredakteurin des Ophthalmic Journal, dem „Spektrum für Augenheilkunde“. Außerdem war sie Herausgeberin von 4 Büchern und hat viele Buchartikel geschrieben. Dr. Binder ist Mitglied in vielen Augengesellschaften, einschließlich der American Academy of Ophthalmology, der Gesellschaft für Augenheilkunde und Augenheilkunde (ARVO), der Retina Society, der Macula Society, des Club Jules Gonin, der Association of Retina Specialists und der Austrian and Viennese Ophthalmic Society.

Sie war von 2004 bis 2009 Präsidentin der Österreichischen Ophthalmologischen Gesellschaft und von 2009 bis 2011 Sekretärin der Österreichischen Ophthalmologischen Gesellschaft und Mitglied des Ärztlichen Beirates des österreichischen Gesundheitsministers und des Bürgermeisters von Wien.

Seit 2012 ist sie als außerordentliche Professorin für klinische Ophthalmologie am Weill Cornell Medical College / New York tätig.

Dr. Binder hat viele junge Augenärzte ausgebildet und chirurgische Trainingswochen (Wet Labs) für die praktische Ausbildung sowie mehrere internationale Konferenzen in Wien organisiert. Sie nahm am Projekt der American Austrian Foundation, der European Society of Ophthalmology teil und ist regelmäßig eingeladener Dozent und Redner bei nationalen und internationalen Treffen.

 

Univ. Professor Dr. Susanne Binder
Sigmund Freud Universität
Freudplatz 1, 1020 Wien

oder

Büro:
Univ. Professor Dr. Susanne Binder
Zeltgasse 1/9
Tel: 0043 1 405 64 02
FAX: 0043 1 405 64 02
mailto: susanne@susannebinder.com

 

Chirurgie

Michael Gnant
Michael Gnant
Wien / AT

Univ.-Prof. Dr. Michael Gnant

Michael Gnant

Wien / AT

Chirurgie

Professor Michael Gnant, MD, FACS

Dr. Michael Gnant is Professor of Surgery and Director of the Department of Surgery at the Medical University of Vienna, Austria. After his studies in Vienna and Munich he specialized in surgery and surgical oncology, and worked as Visiting Scientist at the NIH in the US. Professor Gnant has published more than 400 original papers in peer-reviewed journals. His cumulative impact factor is more than 3.000, with >15.000 citations, an average citation index of 36, and an h-index of 50. He has has given numerous lectures at international meetings and has been the recipient of multiple international awards.

Dermatologie

Hubert Pehamberger
Hubert Pehamberger
Wien / AT

Univ.-Prof. Dr. Hubert Pehamberger

Hubert Pehamberger

Wien / AT

Dermatologie

Univ.-Prof. Dr. Hubert Pehamberger

Geboren in Wien, verheiratet, 1 Sohn

Ausbildung:

1969 – 1975  Studium der Medizin in Wien, Promotion

1975 – 1981  Dermatologische Facharztausbildung an der I.Universitäts-Hautklinik Wien

1985             Habilitation – Das Maligne Melanom der Haut

1997             Berufung zum Universitätsprofessor für Dermatologie und Venerologie

Auslandsaufenthalte:

National Cancer Institute (NIH) Bethesda, Maryland

Harvard Medical School, MGH, Boston

Bisherige Funktionen:

  • Vorstand der Universitätsklinik für Dermatologie der Medizinischen Universität Wien
  • Leiter der Klinischen Abteilung für Allgemeine Dermatologie der Universitätsklinik Dermatologie in Wien
  • Leiter des Ludwig Boltzmann Instituts für Klinisch Experimentelle Onkologie

Wissenschaftliche Publikationen:

  • 280 wissenschaftliche Publikationen in Peer-reviewed Journalen – zitiert als „pehamberger h“ in pubmed.com (cumulativer Impact-Faktor >1.200)
  • Zahlreiche Buchbeiträge
  • Mehr als 200 eingeladene Vorträge bei internationalen Kongressen

Lehre:

  • Lehrauftrag als Klinikvorstand
  • 32 Dissertationen und Diplomarbeiten
  • Ausbildungsverantwortlicher für die Facharztausbildung
  • Lehrtätigkeit an der Schwesternschule des Allgemeinen Krankenhauses der Stadt Wien und Schwesternschule der Barmherzigen Brüder

Öffentlichkeitsarbeit – Prävention von Hautkrebs:

Melanom-Hautkrebs-Aufklärungskampagnen „SONNE OHNE REUE“

jährlich seit 1988 bis dato

Funktionen in akademischer Selbstverwaltung an der Medizinischen Universität Wien:

  • Mitglied des Gründungskonvents und des akademischen Senats (4 Perioden) der Medizinischen Universität Wien und Sprecher der ProfessorInnen-Kurie (bis dato)
  • Leiter des Teilprojekts 2 –Zentrumsbildung des Projekts UNIMED 2020 der Medizinischen Universität Wien und der Teilunternehmung AKH (2013-2015)
  • Mitglied des Fakultätskollegiums und von Personal-, Struktur-, Betriebsführungs- und Klinikkommission der Medizinischen Fakultät sowie von zahlreichen Habilitations- und Berufungskommissionen (seit 1983)
  • Mitglied des Kuratoriums (Aufsichtsrat) der Donau-Universität Krems (2 Perioden)

Funktionen in nationalen wissenschaftlichen Gremien:

  • Österreichische Gesellschaft für Dermatologie und Venerologie (ÖGDV)

(Präsident 2007/2008 – permanentes Vorstandsmitglied)

  • Arbeitsgemeinschaft Melanom und dermatologische Onkologie der ÖGDV (Vorsitzender)
  • Österreichische Krebsgesellschaft – Österreichische Krebshilfe (Ausschussmitglied)
  • Verein zur Förderung von Wissenschaft und Forschung AKH (2x Präsident, Vizepräsident, Generalsekretär)
  • Ärztliche Jury des Theodor Billroth-Preises (Mitglied) 1990-1997)
  • Vorsitzender des Beratergremiums des Jubiläumsfonds der Österreichischen

Nationalbank (bis dato)

Funktionen in internationalen wissenschaftlichen Gremien:

  • European Association of Dermato-Oncology (EADO) (Präsident 2000-2010, Board Member)
  • WHO Melanoma Programme (Member)
  • Malignant Melanoma Group of the EORTC (Member)
  • Kommission zur Früherkennung und Prävention von Hautkrebs, Deutschland

(Mitglied und Vertreter Österreichs)

Organisation Nationaler und Internationaler Kongresse:

  • 16th World Congress on Cancers of the Skin, Wien, 30.8. bis 3.9.2016 – in Vorbereitung
  • 7th World Congress on Melanoma, Wien, 2009
  • Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie, Wien, 2007 und 2008
  • 10th World Congress on Cancers of the Skin, Wien, 2005
  • Meeting of the European Association of Dermato-Oncology (EADO), Wien, 2001
Andreas Steiner
Andreas Steiner
Wien / AT

Prim. Univ.-Prof. Dr. Andreas Steiner

Andreas Steiner

Wien / AT

Dermatologie

EDUCATION AND CAREER

May 30th, 1973   High school graduation

1973-1980            Medical School, University of Innsbruck, Austia; M.D. graduation: March 26th, 1980

1980-1983            Internship, Hospital Gmunden, Austria

1983-1989            Residency training in Dermatology, Department of Dermatology I., University of Vienna, Medical School

Nov. 27th, 1987  Medical specialist for Dermatology and Venerology

Dec. 5th, 1994      Assistant Professor for Dermatology and Venerology (“venia legendi”)

Dec. 15th. 1995    Clinical investigator (GCP-training and exam)

Many clinical studies designed and performed

July 1st, 1998        Associate Professor for Dermatology and Venerology, University of Vienna

Since 2008           Head of the Department of Dermatology, Krankenhaus Hietzing, Vienna

Diabetologie

AndreasFesta
Andreas Festa
Wien / AT

Univ.-Prof. Dr. Andreas Festa

AndreasFesta

Wien / AT

Diabetologie, Management Board,

Univ. Prof. Dr. Andreas Festa

 

Univ. Prof. Dr. Andreas Festa ist Facharzt für Innere Medizin und Arzt für Allgemeinmedizin; seine klinische Ausbildung erfolgte in Wien, diese umfasste im speziellen die Diabetologie in allen Facetten. 2001 erfolgte die Habilitation an der Universität Wien, 2012 erfolgte die Ernennung zum Universitätsprofessor. Nach erfolgreicher akademischer Karriere unter anderem als research fellow an der Abteilung für klinische Epidemiologie in San Antonio, Texas, USA, setzte Prof. Festa seine Forschungsaktivitäten in der pharmazeutischen Industrie fort, wo er über einen Zeitraum von 15 Jahren bei internationalen Unternehmen wechselnde Rollen mit zunehmender Seniorität ausübte.

 

Prof Festa wurden mehrere nationale (Paracelsus Preis) und internationale (Deutsche Diabetes Gesellschaft) Forschungspreise verliehen. Er ist als Gutachter für nationale und internationale Journale tätig; so hat er mehr als 150 reviews für Diabetes Care verfasst, wo er auch Mitglied des „Editorial Boards“ war und als „Gold reviewer“ ausgezeichnet wurde. Weiters ist er Autor von über 55 Artikeln in internationalen „Top-Journals“, inklusive The Lancet, Circulation, Diabetes Care, JCEM, Am J Cardiol, ATVB, Diabetologia, Diabetes; Impaktpunkte über 350, mehr als 150 als Erstautor.

 

Prof Festa ist derzeit leitender Oberarzt der Diabetes- und Stoffwechselambulanz im LK Stockerau/Nö. Als Berater und Vortragender für Gesundheitsunternehmen in den Bereichen Diabetes, Stoffwechsel und CV-Erkrankungen umfasst Prof Festa`s Expertise ein weites Spektrum von strategischer Beratung bis zu ärztlicher Fortbildung.

Bernhard Ludvik
Bernhard Ludvik
Wien / AT

ao Univ.-Prof. Dr. Bernhard Ludvik

Bernhard Ludvik

Wien / AT

Diabetologie

CURRENT POSITION AND FUNCTIONS

Head/Department of Medicine 1 (Endocrinology/Diabetes/ Nephrology), Rudolfstiftung Hospital

Associate Professor of Medicine, Medical University of Vienna, Austria

Member of the Editorial Board of Obesity Facts-The European Journal of Obesity

Member of the Editorial Board of Hamdan Medical Journal

 

Past President Austrian Obesity Association

President of the Diabetes Initiative Austria

Past-President of the Austrian Diabetes Association

 

Member of the Scientific Committee of the IFSO (International Federation for the Surgery of Obesity)

Member of the Local Organisation Committee of the 50th EASD (European Association for the Study of Diabetes) 2014 in Vienna

 

SCIENTIFIC INTEREST

Research in obesity, metabolic syndrome and diabetes, more than 130 peer-reviewed publications in high ranked journals, reviewer in top journals, successful application for research grants, organisation of national and international meetings

 

RESEARCH HIGHLIGHTS

Basic research on the pathogenesis and therapy of type 2 diabetes, the metabolic syndrome and obesity

Clinical research on the treatment of obesity, diabetes and lipid metabolism as the principal investigator of numerous studies and clinical trials in phases 1, 2 and 3

Nutritional Medicine

Original publications (Medline: 147) in many top journals, review articles, book contributions, numerous presentations at national and international congresses, organization of national and international congresses, reviews for top journals (e.g. Diabetes, Diabetes Care, Diabetologia, European J. Clin. Investigation)

 

Gastroenterologie

Ludwig Kramer
Ludwig Kramer
Wien / AT

Prim. Univ.-Prof. Dr. Ludwig Kramer

Ludwig Kramer

Wien / AT

Gastroenterologie

Date and place of birth:30-11-1964, Wolfsberg, Austria

Citizenship: Austria

Family Status: married, 1 son

School education: Primary School 1971-74, secondary 1975-83, maturity exam 23-6-1983

 

Medical education: 1984-1992 Vienna University Medical School; 1990/91 Research Fellow,       1st Medical Clinic, University Vienna, with Prof K. Lenz, Prof G. Grimm.

Postgraduate Education: 1992-1998: Specialist training in Internal Medicine, Department of Medicine IV (Head: Prof A.Gangl)

1996: Research Associate with Prof Roger Williams CBE, Institute of Liver Studies, King’s College Hospital, London, UK.

2001: Specialist degree for Medical and General Intensive Care Medicine

2002: Radiology training (sonography, computed tomography).

2003/5: in-depth training and Specialist degree in Gastroenterology (endoscopy, clinical hepatology, gastroenterology)

2004- 2007: INTERREG diplomate for clinical research and EBM, Vienna School of Clinical research

Invitations: Invited lecturer at national and international scientific meetings organized by the European Association for the Study of Liver diseases (EASL), European Society of Nephrology, Dialysis and Transplantation (EDTA), National Institute of Health (Bethesda, USA), European Society for Artificial Organs (ESAO), European Society of Intensive Care Medicine, Eur Academy Ansthesiol., Societa italiana di anestesia analgesia rianimazione e terapia intensiva, ISFA, Fortis Health Care India, etc.

Peer reviewer (selection): Gastroenterology, Hepatology, J Hepatology, Intensive Care Medicine, Critical Care Medicine, Liver International, Nephrol Dial Transplant, Am J Med., Am J Nephrol., Eur J Clin Invest, Eur J Ultrasound, Wiener Klin Wochenschrift, Clin Neurophysiol, Therapeutic Apheresis and Dialysis, diabetologia, Diabetes Care, J Hum hypertension, PLOS ONE, Therapeutics and Clinical Risk Management; Hepatic Medicine: Evidence and Research, Journal of Gastroenterology and Hepatology.,

Awards:

12/1999 Theodor-Billroth Prize (1.) Ärztekammer Wien

10/2000 Paracelsus Award, Austrian Society for Internal Medicine.

12/2011: Health Prize, City of Vienna

Academic positions:

2002: Lecturer in Internal Medicine, University of Vienna

2005-2007: Program coordinator for Internal Medicine, Bernhard Gottlieb Zahnklinik, Vienna

2006-2007 Voting Member, Study Commission, Medical University Vienna

Other activities:

2010-2013: Delegate for Vienna Health Goals, City of Vienna

2010-2013: Member of the Task Force Obesity, City of Vienna

2009-current: Referent for professional policies, Austrian Society for Gastroenterology & Hepatology

March 2013: National Delegate, European Board of Gastroenterology & Hepatology (EBGH)

January 2014: Chair, CME committee, EBGH

2015: elected representative of Hietzing physicians

Current clinical position: March 1, 2008: Head, 1st Dept with Gastroenterology, Krankenhaus Hietzing, Vienna.

Clinical trial experience: 1998-2015 Principal Investigator of academic studies in Hepatology, Intensive Care Medicine and General Internal Medicine, and of phase 2-4 studies involving patients with liver disease, viral infection, bleeding and coagulation disorders, inflammatory bowel disease and extracorporeal detoxification in liver disease.

Gesundheitsökonomie

Dominique Dubois
Dominique Dubois
Brüssel / BEL

Prof. Dr. med. Dominique Dubois

Dominique Dubois

Brüssel / BEL

Gesundheitsökonomie

Dominique Dubois MD FBCPM FFPM

Physician Specialist in Pharmaceutical Medicine. Lecturer in Pharmacoeconomics & Patient Reported Outcomes Research. Vice-Chairman PHARMED PharmaTrain Centre of Excellence. Author of >50 publications in peer-reviewed journals. Specialty Chief Editor of Frontiers in Pharmaceutical Medicine and Outcomes Research.

Dominique contributed to the FDA PRO draft guidance, the EMEA reflection paper on HRQL measures, and an expert guidance report on coverage decision-making in orphan diseases. He was also largely instrumental in achieving a successful NICE Single Technology Appraisal.

Health Economy and Health Technology Assessment (HTA)

Lieven Annemans
Lieven Annemans
Ghent/BEL

Lieven Annemans

Lieven Annemans

Ghent/BEL

Health Economy and Health Technology Assessment (HTA)

Lieven Annemans is a Senior Professor of Health Economics at the Faculty of Medicine at Ghent University, Belgium. He has 20 years of experience in international health economics research. For many years he is a well sought expert consultant and lecturer in health technology assessment (HTA). He was advisor to the Belgian Minister of Health from 2001 to 2003 and president of the Flemish health council from 2003 to 2009. He is Past-President of ISPOR (International Society of PharmacoEconomics and Outcomes Research). He published more than 250 papers and several books on health economics and HTA.

Keith Tolley
Keith Tolley
Buxton / UK

Keith Tolley

Keith Tolley

Buxton / UK

Health Economy and Health Technology Assessment (HTA)

Keith’s background is primarily in health economics and health technology assessment. He has worked both in academia (University of York – Centre for Health Economics and University of Nottingham, UK 1987-1997) and for several pharmaceutical companies, including GSK, Pfizer and Ortho Biotech (1997-2005) and in consultancy as a Director at Mapi Values.  Keith is now  Director of Tolley Health Economics, a company he set up in 2008 to provide strategic advice and consultancy in the area of the use of health economic analysis and HTA methods to support the market access of pharmaceuticals.  Keith has direct experience of health technology assessment as performed by NICE for England and Wales and the SMC in Scotland, and reimbursement and pricing issues around Europe. Keith provides strategic advice and consultancy on company submissions to NICE and SMC across a range of disease areas. He has also reviewed and been involved in the development of health economic models for NICE/SMC and other HTA bodies, and has reviewed economic models for their suitability (e.g. structure, data inputs) for drug reimbursement purposes.

Keith is also a health economics assessor with the Scottish Medicines Consortium (the HTA body advising on new drug reimbursement in Scotland), a position he has had since 2005, having previously been an industry representative on the NDC.  In 2013 Keith also became an assessor for the All Wales Medicine Strategy Group and has provided expert advice as part of the NICE Early Scientific Advise Programme.  Keith has published extensively in health economics and is the author of two books and several edited books.  Keith has a BA and an MPhil from the University of Leeds.

Kardiologie

Andrea Podczeck-Schweighofer
Andrea Podczeck-Schweighofer
Wien / AT

Prim. Univ.-Doz. Dr. Andrea Podczeck-Schweighofer

Andrea Podczeck-Schweighofer

Wien / AT

Kardiologie

Nach der Matura 1972 – 1973 Studium der Sozialwissenschaften sowie Philosophie an der Universität Bonn

Ab 1973 Medizinstudium (Vorklinik Universität Bonn, Klinischer Abschnitt und Promotion Universität Wien)

Turnusausbildung am Wilhelminenspital

Ausbildung zur Fachärztin für Innere Medizin am Wilhelminenspital (3. medizinische Abteilung) sowie an der Universitätsklinik Düsseldorf

Additiv-Fachärztin für Kardiologie

Additiv-Fachärztin für Intensivmedizin

 

Auslandsaufenthalte im  – St.Bartholomew´s Hospital London 1984

– Universitätsklinik Düsseldorf 1986/1987

1995: Venia docendi für Innere Medizin an der Universität Wien

Seit 2004 Ärztliche Leiterin/ Primaria an der 5. medizinischen Abteilung/ Kardiologie des Kaiser Franz Josef-Spitals

Seit 2013 Ordentliches Mitglied des Landessanitätsrats für Wien

 

Vorstandsmitglied der Österreichischen Kardiologischen Gesellschaft

2015 Präsident elect der Österreichischen Kardiologischen Gesellschaft

2015 Fellow of the European Society of Cardiology (FESC)

2016 Berufung zum Professor für Kardiologie an der Medizinischen Fakultät der Sigmund Freud Universität Wien

Georg Delle-Karth
Wien / AT

Prim. Priv. Doz. Dr. Georg Delle-Karth

Wien / AT

Kardiologie

Curriculum Vitae Prim. Priv. Doz. Dr. Georg Delle Karth

Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel
Wolkersbergenstrasse 1, A-1130 Vienna
Geburtsdatum: 3.2.1968

E-Mail: georg.delle-karth@wienkav.at
Tel:       (+43 1) 80110-2511
Fax:      (+43 1) 80110-2687

Ausbildung und bisherige berufliche Laufbahn

Seit 2014-  Abteilungsvorstand an der 4. Medizinischen Abteilung mit Kardiologie im Krankenhaus Hietzing mit Neurologischem Zentrum der Stadt Wien

2014- Gründung einer Ordination

2014- Direktor des AKH-Wien Herzkatheterlabors

2009-2014- Ko-Direktor des AKH-Wien Herzkatheterlabors

2007- Habilitation, Verleihung der Lehrbefugnis als Privatdozent für Innere Medizin an der Medizinischen Universität Wien

2007- „Senior Clinical Specialist“ Kardiologie zum Aufbau des Privatkrankenhauses „Prince Court Medical Center“, Kuala Lumpur, Malaysien als Entsandter der Medizinischen Universität Wien

2006- Zusatzfacharzt: Kardiologie

2004-2014- Mitglied des AKH-Wien Herzkatheter-Teams

2004- Zusatzfacharzt: Internistische Intensivmedizin

2003-2008- Stellvertretender ärztlicher Leiter der kardiologischen Intensivstation am AKH-Wien

2001-2002- Mitglied des Echokardiographielabors und stationsführender Facharzt auf der allgemeinen kardiologischen Bettenstation

2000- Facharzt für Innere Medizin

1994-2000- Assistenzarzt in Ausbildung Universitätsklinik für Innere Medizin II/Kardiologie, Wien

1987-1993- Medizinstudium an der Universität Wien

 

Wissenschaft

Seit 2014- Leiter des Karl Landsteiner Instituts für kardiovaskuläre und intensivmedizinische Forschung

Seit 1994- Über 60 Publikationen in medizinischen Journalen mit „Peer Review“

http://www.ncbi.nlm.nih.gov/pubmed/?term=delle+karth+or+karth+gd

 

Mitgliedschaften

Seit 2012-  Committee member (congress organization & educational committee) der Acute Cardiac Care-Association der European Society of Cardiology

2008-2010- Arbeitsgruppenleiter „Kardiovaskuläre Intensivmedizin“ der ÖKG

Seit 2008- Arbeitsgruppenmitglied „Interventionelle Kardiologie“; Nucleus seit 2016

2005-2010- Delegierter der ÖKG bei der Leitlinienerstellung „Kardiogener Schock“ der Deutschen Gesellschaft für Kardiologie, ÖGIAIM der ÖKG und anderer Fachgesellschaften

Seit 2002- Österreichische Kardiologische Gesellschaft – European Society of Cardiology

Heinz Weber
Heinz Weber
Wien / AT

Univ.-Prof. Dr. Heinz Weber

Heinz Weber

Wien / AT

Kardiologie

Prim. Univ.-Prof. Dr. Heinrich Weber

MD, FESC, FACC

  • Born in Vienna, Austria, EU
  • May 1973: MD, Medical School of the University of Vienna meduniwien.ac.at
  • 1973-76 GP-Training:  Kaiserin Elisabeth Hospital, and several other Viennese City Hospitals.
  • 1976-2003 University of Vienna – Medical Faculty/ AKH (Vienna General Hospital, akhwien.at )
  • 1976 – 1980 Training in General Internal Medicine:
    • Kardiologischen Univ.-Klinik, Dir. Univ.-Prof. Dr. F. Kaindl
    • Medizinischen Univ.-Klinik, Dir. Univ.-Prof. Dr. G. Geyer
  • 1980 – 1987 Training in Cardiology and Intensive Care Medicine
    • Staff member at the Kardiologische Univ.-Klinik since 1982
    • 1986 PhD, Assoc. Prof. (Habilitation and Univ.-Dozent )
    • 1987 Specialist in Cardiology
  • 1987 – 1994 Staff Member of the Univ.-Clinic Inter. II – Depmnt. of Cardiology
    • 1991 tit. Ao Univ.-Professor of Internal Medicine
    • 1992 Specialist of Intensive Care Medicine
    • Responsibilities
      • 7 years consultant
      • 3 years Director of the Intensive Care Unit (ICU) 13H3, AKH
      • 1 year Vice-Director of the Catheter-Labs (4 biplane devices), AKH.
    • 1994 – 2003 First Director (Primarius) of the Med. Dpt. Cardiology, Kaiser Franz Josef Hospital in Vienna ( http://www.wienkav.at/kav/kfj )
    • 2004 – 31.1.2013 Director of the 1st Medical Department, Donauspital (Danube-Hospital), SMZ-Ost ( http://www.wienkav.at/kav/smz/ )

Medical Training:

  • Training in invasive and interventional Cardiology:
    • Diagnostic: More than 20 years experience in diagnostic investigations of the heart, including several thousand Coronary Angios.
    • Interventions:
      • More than 1.800 PTCAs since 1988 incl. many complexed multi-vessel procedures, 90% Stent-implantations, (50% DES).
      • Intra-coronary Ultrasound (IVUS) plus virtual histology (VH).
      • 1993 Coronary-Angioscopies (100 cases).
      • PTCA -Courses (Frankfurt 1988, Toulouse 1990 and 1991, Jerusalem, Madrid, Milano 2000, Lausanne 2003, Lugano 2006, Barcelona 2008)
      • Experience with FFR and OCT (optical Coherenz-Tomographie)
      • Experience with „non-invasive“ Coronary-Angiography (Multislice CT incl.  Calzium-Scoring).
    • Elektrophysiology
      • 400 diagnostic and therapeutic Procedures of different nature.
      • Programmed Ventricular Stimulations.
      • Electrophysiology-Trainings Courses at St. Georgs Hospital, London (1990, 1991 Prof. Camm)
    • Experience in Intensive Care Medicine
      • Director of the Intensive Care Unit (ICU) 13H3, AKH from 1991 – 1994 (8 ICU beds)
        • 96 Beds at 3 wards,
        • ICU with 12 Intensive-Positions
        • Catheter-Labor (biplane device)
        • Electrophysiologic Labor
        • 32 MDs, among them 18 Specialists of Internal Medicine, Cardiology, Intensive Care Medicine and Angiology.
        • Special OPDs for PM, ICDs, Angiology etc.

Scientific Activities:

About 200 Publications, many of them in peer reviewed Journals dealing with Rhythmology (Longterm-ECG, Pacemaker, ICD, PV-Stimulations, antiarrhythmic drugs etc.), acute MI (STEMI in Vienna, in Austria, OCT, IVUS etc), in Resuscitation (Book about Emergency Medicine, 3 Edit.), Health economy, Epidemiology, participation in many MC RCTs relating to anticoagulation and lysis Therapy versus acute interventions. Many oral presentations, invitations and chairmanships (s. publication list) until today.

International Activities:

  • Fellow of the European Society of Cardiology (FESC) ( www.escardio.org )
  • Fellow of the American College of Cardiology (FACC) ( www.acc.org )
  • Diploma of a “European Cardiologist” (2002)
  • President of the Austrian Cardiac Society 1999/2000 (Österr. Kardiologischen Gesellschaft www.atcardio.org )
  • Board member of the Austrian Cardiac Society 1998 – 2002
  • Honorary Member of the Slovak Cardiac Society
  • Board Member of the Viennese Medical Association (Gesellschaft der Ärzte in Wien www.billrothhaus.at )
  • Vice-President of the Viennese Red Cross 2004 – 2012 ( http://www.w.roteskreuz.at )
  • President of the UEMS-Cardiology Section 1998-2002 (Union Medicine Europeene Specialistes, http://www.uems.net )
  • Founding-Chairman of EBAC (European Board for accreditation in Cardiology, ( www.ebac-cme.org ) 1999,.
  • Co-Chairman of the EBSC (European Board for the Speciality of Cardiology), (s.o., http://www.cardiology-accreditation.org/ ).
  • UEMS-Cardiology Section ( www.uems-cardio.eu ) Member of the Executive Commitee since 1998
  • EBAC ( www.ebac-cme.org ): Member of the Advisory Commitee
  • European Cardiology Society Foundation ( www.e-cs-f.org ) – Chairman of the Council
  • Member of the Scientific Board of the Austrian Academy of Physicians (www.arztakademie.at)

klinische Pharmakologie

Martin Brunner
Martin Brunner
Wien / AT

Univ.-Doz. Dr. Martin Brunner

Martin Brunner

Wien / AT

klinische Pharmakologie

Bernd Rosenkranz
Bernd Rosenkranz
Kapstadt / Südafrika

Prof. Dr. med. Bernd Rosenkranz

Bernd Rosenkranz

Kapstadt / Südafrika

klinische Pharmakologie

Prof Dr. med. Bernd Rosenkranz, FFPM

 Prof Bernd Rosenkranz holds a medical degree from the University of Düsseldorf, is board certified Clinical Pharmacologist in Germany and South Africa, and Fellow of the Faculty of Pharmaceutical Medicine (FFPM). In 1994, he qualified as university lecturer (habilitation) at the Medical Faculty of the Philipps University Marburg with the venia legendi for Clinical Pharmacology; in 2001 he received the venia legendi for Clinical Pharmacology from the Medical Faculty, Humboldt University Berlin (Charité).

He spent 23 years in industry, as Director of Clinical Pharmacology at Hoechst/Hoechst Marion Roussel in Germany, France and USA, Chief Medical Officer at 3ClinicalResearch in Berlin/Hennigsdorf, Germany, and Vice President Clinical Development at Jerini, Berlin, Germany, where he was responsible for the world-wide clinical programme of icatibant in hereditary angioedema. In 2008, he was appointed Professor and Head of the Division of Clinical Pharmacology (Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa) from which he retired in 2016. In 2010, he established a postgraduate programme in Pharmaceutical Medicine / Medicines Development which received recognition as Centre of Excellence in 2014 by the PharmaTrain Federation.

Bernd Rosenkranz is co-founder and President of the Fundisa African Academy of Medicines Development, board member of the South African Society for Basic and Clinical Pharmacology (SASBCP), and secretary of the College of Clinical Pharmacologists (Colleges of Medicine of South Africa), He is member of various international organisations, such as the International Committee of the UK Faculty of Pharmaceutical Medicine, the Membership Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR), the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT), the Arbeitsgemeinschaft für Angewandte Humanpharmakologie (AGAH), the American Society for Clinical Pharmacology and Therapeutics (ASCPT), the PharmaTrain Federation, and the PharmaTrain Certification Board.  He is co-chair of the IFAPP-PharmaTrain “Medicines Development and Regulation: Working Group on Education in Low and Middle Income Countries”. He was chair of the Finance Committee of the 17th World Conference of Basic and Clinical Pharmacology (WCP2014) held in Cape Town.

His work is presented in 102 original publications, 17 book chapters, 64 invited lectures/chairmanships, and 126 conference presentations. He is Associate Editor of Frontiers in Pharmaceutical Medicine and Outcomes Research and of the Journal of Medicines Development Sciences.

Bernd Rosenkranz is board member of the Manenberg Aftercare Centre, Manenberg, Cape Town.

Harry Selker
Harry Selker
Boston / USBoston/US

Prof. Dr. med. Harry Selker

Harry Selker

Boston / USBoston/US

klinische Pharmakologie

Harry P. Selker, MD, MSPH is Dean of Tufts Clinical and Translational Science Institute (CTSI) (www.tuftsctsi.org) at Tufts University, and Executive Director of the Institute for Clinical Research and Health Policy Studies (www.icrhps.org) at Tufts Medical Center.  As Dean of Tufts CTSI, he provides leadership and is responsible for the programs and infrastructure that support clinical and translational research at the Tufts University Schools and affiliated hospitals, and other academic, community-based, and industry CTSI partners. He practices medicine at Tufts Medical Center.

 

Dr. Selker‘s research focuses on the development of treatment strategies, decision aids, and systems aimed at improving medical care.  He is known for a series of studies of the factors influencing emergency cardiac care and for development of „clinical predictive instruments,“ mathematical models that are used as decision aids.  They provide emergency physicians and paramedics with predictions for their patients’ likely cardiac diagnoses and outcomes for real-time use in clinical care.  This has included conduct of multiple large national clinical effectiveness trials that have demonstrated better treatment and clinical outcomes for patients with acute coronary syndromes. Additionally, Dr. Selker has done research to advance clinical study design, execution, issues around informed consent, data analysis, mathematical predictive modeling of medical outcomes, and comparative effectiveness research.

 

Dr. Selker also has contributed to health services and health policy research, with a focus on translational research that ultimately has impact on the public’s health.  He has advised policymakers around healthcare delivery and medical research, including the House and Senate authors of the Affordable Care Act.  Nationally, Dr. Selker has served as president of the Society of General Internal Medicine, of the Society for Clinical and Translational Science, and of the Association for Clinical Research Training, and serves on boards of organizations and Federal agencies.  He is currently President of the Association for Clinical and Translational Science and Chairman of the Clinical Research Forum.

Michael Wolzt
Michael Wolzt
Wien / AT

ao Univ.-Prof. Dr. Michael Wolzt

Michael Wolzt

Wien / AT

klinische Pharmakologie

klinisches Projektmanagement

Martin Robinson
Martin Robinson
Harrow/ GB

Martin Robinson

Martin Robinson

Harrow/ GB

klinisches Projektmanagement

Mikrobiologie

Manfred Dierich
Manfred Dierich
Innsbruck /AT

o Univ.-Prof. Dr. Manfred Dierich

Manfred Dierich

Innsbruck /AT

Mikrobiologie

O. Univ.-Prof. Manfred P. Dierich studied medicine in Cologne, Vienna, Graz and Ottawa 1961-1966. Approval as Dr.med. 1968.

1970 Start of training in Medical Microbiology and Immunology in Mainz (1973-1975 Scripps Clinic and Research Foundation, La Jolla, California); 1977 Habilitation in Medical Microbiology; 1979 Professor of Medical Microbiology in Mainz.

1983 Full Professor of Hygiene at the University of Innsbruck and chairman of the Institute of Hygiene until the end of 2009.

He held various positions such as speaker of the professors of the medical faculty , vicerector and rector of the Medical University of Innsbruck and chairman of several commities in the university and in science politics. His science centered around „Host parasite relationship „, specifically complement and macrophages of special importance was his AIDS Research. He published several hundred scientific papers.

Onkologie

Michael Micksche
Michael Micksche
Wien / A

Univ.-Prof. Dr. Michael Micksche

Michael Micksche

Wien / A

Onkologie

Gerald Prager
Gerald Prager
Wien / AT

Ass. Prof. PD Dr. Gerald Prager

Gerald Prager

Wien / AT

Onkologie

Christoph Zielinski
Christoph Zielinski
Wien / AT

Univ.-Prof. Dr. Christoph Zielinski

Christoph Zielinski

Wien / AT

Onkologie

Vorstand, Klinik für Innere Medizin I; Leiter, Klinische Abteilung für Onkologie und Leiter des Comprehensive Cancer Center, Medizinische Universität Wien und AKH

1970-1976   Studium an der Medizinischen Fakultät der Universität Wien

1976-1978   Assistenzarzt am Institut für Immunologie der Universität Wien

1978-1983  Ausbildung zum Facharzt für Innere Medizin

1979-1980  Fellow am Cancer Research Center, Tufts University Medical School, Boston, USA

1986              Habilitation in Klinischer Immunologie

1989              Erweiterung des Habilitationsfachs auf das Gesamtgebiet der Inneren Medizin

1992              Ernennung zum außerordentlichen Universitätsprofessor (lt. §31 UOG 1975) für Klinische

Immunologie und Innere Medizin unter besonderer Berücksichtigung der internistisch-

experimentellen Onkologie

1999 –           Gründer und Präsident der Central European Cooperative Oncology Group

1999 – 2012 Koordinator der Initiative Leben mit Krebs

seit 2001     Leiter der Klinischen Abteilung für Onkologie an der Universitätsklinik für Innere Medizin I

seit 2004    Vorstand der Universitätsklinik für Innere Medizin I

seit 2010     Leiter des Comprehensive Cancer Center der Medizinischen Univ. Wien und des Allgemeinen Krankenhauses Wien

Mitgliedschaften/Memberships

Präsident der Central European Cooperative Oncology Group (CECOG), 2000 –

European Society for Medical Oncology (2014-2017: Mitglied des Executive Boards)

American Society for Clinical Oncology

American Association for Cancer Research

Deutsche Gesellschaft für Innere Medizin

Österr. Gesellschaft für Hämatologie und Onkologie

Österr. Gesellschaft für Innere Medizin

Pharmakologie

Sandor Kerpel-Fronius
Sandor Kerpel-Fronius
Budapest / HUBudapest/HU

Prof. Dr. med. Sandor Kerpel-Fronius

Sandor Kerpel-Fronius

Budapest / HUBudapest/HU

Pharmakologie

Professor of Clinical Pharmacology

Semmelweis Medical University

Department of Pharmacology and Pharmacotherapy

Budapest, Hungary

 

Dr. Kerpel-Fronius was born in Budapest, Hungary, November 4, 1940. He obtained medical diploma at the Semmelweis University in 1964. At the same university he received board certificates in Clinical Laboratory Sciences and Clinical Pharmacology in 1977 and 1980, respectively. From 1964 to 1975 he worked in neurobiology at the Semmelweis University. In 1967-68 he was a research fellow at the Karolinska Institute, Stockholm and 1972 to 1974 a Sloan Fellow at the Maryland Psychiatric Research Center in the US. From 1975 to 1989 he led a clinical pharmacologic research group at the National Institute of Oncology in Hungary. In 1988 he spent a sabbatical year at the Cancer Center of the Wayne State University, Detroit, US. 1989-2001 he worked in clinical drug development within the international pharmaceutical industry. In 2001 he became Professor of Clinical Pharmacology at the Department of Pharmacology and Pharmacotherapy of the Semmelweis University. He was the General Director of the Hungarian National Institute of Pharmacy (Hungarian Drug Regulatory Agency) in 2002. Presently he is retired but continues to teach clinical pharmacology as Senior Scientific Advisor. In addition, he participates as lecturer of medicines development at several international courses. Committee memberships: IFAPP Board of Officers, Head of the IFAPP Working Group on Ethics; Educational Subcommittee of the EACPT (finished 2015); Executive Board of the IMI-PharmaTrain; Member of the St Steven Academy of Sciences, Hungary. Chairman of the Natural Sciences Section, 2001).

Robert Mader
Robert Mader
Wien / AT

ao Univ.-Prof. Dr. Robert Mader

Robert Mader

Wien / AT

Pharmakologie

Prof. Robert M. Mader, D. Sc.
Clinical Division of Oncology, Department of Medicine I
Comprehensive Cancer Center of the Medical University of Vienna
Austria

Examinations and degrees:
D.Sc. in Technical Chemistry (Dr.techn.rer.nat., 1986) and Diploma in Technical Chemistry (DipI.lng., 1983)
Appointments:
Director for Translational Research at the Department of Medicine I, Medical University of Vienna (from 2010) and Associate professor and Program Director for „Molecular Pharmacology“ at the Comprehensive Cancer Center of the Medical University of Vienna
Activities as chair:
from 2010 Coordinator of the Research Cluster „Experimental Therapy and Drug Resistance“ at the Comprehensive Cancer Center Wien
2013-2014 Coordinator of the Task Force „Extravasation“ at the Comprehensive Cancer Center Vienna

Pharmazeutische Medizin

Ingrid Klingmann
Ingrid Klingmann
Brüssel / BEL

MD, PhD, FFPM und FBCPM Ingrid Klingmann

Ingrid Klingmann

Brüssel / BEL

Pharmazeutische Medizin

Ingrid Klingmann, MD, PhD, FFPM, FBCPM
European Forum for Good Clinical Practice (EFGCP), PHARMAPLEX bvba
Physician, specialized in General Medicine, Clinical Pharmacology and Pharmaceutical Medicine with over 30 years of experience in different senior operational and managerial functions in pharmaceutical companies, CROs and academic sites, focussing on clinical trial management, ethical and regulatory aspects.
Since January 2003 she has her own pharmaceutical development and site management support consulting company.
Dr. Klingmann is Chairman of the Board of the European Forum for Good Clinical Practice (EFGCP). On behalf of EFGCP she was and is involved in different FP7- and IMI-funded projects (ICREL, PatientPartner, PharmaTrain, EUPATI, Combacte-Magnet) and with her company in the FP7-funded paediatric LENA project and the IMI-project SPRINTT. Currently Dr. Klingmann is also President of PharmaTrain Federation.
Dr. Klingmann is Module Chair in the post-graduate Master Course in Regulatory Affairs at the University of Bonn, Germany, and is lecturer in the Diploma Course in Clinical Trial Practices and in the ECPM course at University of Basel and in the Pharmed course at Université Libre de Bruxelles, Belgium.

Peter Stonier
Peter Stonier
London / GBLondon/GB

Prof. Dr. med. Peter Stonier

Peter Stonier

London / GBLondon/GB

Pharmazeutische Medizin

Pneumologie

Meinhard Kneussl
Meinhard Kneussl
Wien / AT

Univ.-Prof. Dr. Meinhard Kneussl

Meinhard Kneussl

Wien / AT

Pneumologie

Wolfgang Pohl
Wolfgang Pohl
Wien / AT

Prim. Univ.-Prof. Dr. Wolfgang Pohl

Wolfgang Pohl

Wien / AT

Pneumologie

Psychatrie

Cyril Höschl
Cyril Höschl
Prag / CZ

DrSc., FRCPsych. Cyril Höschl

Cyril Höschl

Prag / CZ

Psychatrie

Cyril Höschl, MD, DrSc, FRCPsych, received his MD grade at the Charles University in Prague in 1974. After completion of his residency he became a research fellow and psychiatrist at the Psychiatric Research Institute (PRI) in Prague and an assistant professor at Charles University in Prague. His research interests included psycho­neuroendocrinology, psychopharma­cology and biological psychiatry. In 1984, professor Höschl presented his original work on neuroendocrine tests in psy­chiat­ry at several Canadian universities. In 1985, he was invited to lecture at New York Uni­versity on his pioneering studies on calcium channel blockers in the treatment of affective disorders.

After the breakdown of communism, he was elected the Dean of the Third Medical Faculty of Charles University in Prague (1990-1997) and appointed profes­sor of psychiatry and a chair at Prague Psychiatric Centre. At present he is the Director of the National Institute of Mental Health at Klecany, Czech Republic. Since 2004 until 2011, he was also a professor of psychiatry at the University of P.J.Safarik in Kosice, Slovak Republic, and Vice-president, Vienna School of Clinical Research, Vienna, Austria. In Prague he coordinates research on neurobiology of schizophrenia and affective dis­or­ders.

In 2007-2008 Professor Höschl was the President of the European Psychiatric Association (EPA). From 2004 to 2010, he was the President of the Czech Medical Academy and from 2008 to 2009 the President of the Federation of European Academies of Medicine (FEAM, Brussels).

Professor Höschl was an author of a fundamental trans­for­mation of the medical curriculum at the 3rd Medical Faculty of Charles University in Prague. He is an honorary editor of Neuroendocrinology Letters, editor-in-chief of Psychiatrie (CZ) and member of the editorial board of International Journal of Psychiatry in Clinical Practice, among others.

Professor Höschl published more than 200 scientific publications, including 3 monographs, and co-edited 5 additional monographs and textbooks.

Radiologie

Walter Hruby
Walter Hruby
Wien / AT

Univ.-Prof. Dr. Walter Hruby

Walter Hruby

Wien / AT

Radiologie

Univ.-Prof. Dr. Walter Hruby, M.D., President of the College of Physicians in Vienna; Emeritus of Radiology Dept. at Vienna’s Danube Hospital. Chairman of the Ludwig Boltzmann-Institute for Digital Radiography & Interventional Radiology until 2016.

His main research focus is Digital & Interventional Radiology. He has given 350+ presentations, published 200+ papers, and edited books and many book chapters. Hruby is member of numerous scientific societies and has received various Honorary Memberships; he functions as a reviewer and co-editor of various medical journals.

Rheumatologie

Josef Smolen
Josef Smolen
Wien / AT

Univ.-Prof. Dr. Josef Smolen

Josef Smolen

Wien / AT

Rheumatologie

Urologie

Georg Schatzl
Georg Schatzl
Wien / AT

Univ.-Prof. Dr. Georg Schatzl

Georg Schatzl

Wien / AT

Urologie